Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV
About Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV
"Das Klinikum Wels-Grieskirchen ist als größtes Ordensspital Österreichs eine Institution der Kongregation der Barmherzigen Schwestern vom heiligen Kreuz und der Franziskanerinnen von Vöcklabruck."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Arbeitsgemeinschaft medikamentoese Tumortherapie
7
Austrian Forum Against Cancer
2
Hoffmann-La Roche
2
GWT-TUD GmbH
1
Clinical Trials at Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV
During the past decade, Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Lenalidomide and Dexamethasone for Treatment of Patients With Acute Myeloma (Light Chain)-Induced Renal Failure
2009-05-01
2014-05-01
Unknown status
50
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
2009-12-01
2019-07-01
Completed
256
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
2007-08-30
2016-05-31
Completed
3,942
Bendamustine Plus Bortezomib Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma
2010-06-01
2013-05-01
Completed
79
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
2010-06-01
2015-05-01
Unknown status
30
Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response
2013-08-30
2018-11-14
Completed
12
Combination of Obinutuzumab and Venetoclax in Relapsed or Refractory DLBCL
2017-01-04
2021-10-19
Completed
22
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
2018-08-02
2025-08-24
Active, not recruiting
2,300
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV"
#1 collaborator was "Hoffmann-La Roche" with 2 trials as a collaborator, "Roche Pharma AG" with 2 trials as a collaborator, "AOP Orphan Pharmaceuticals AG" with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were
collaborators in the rest 18 trials.
Clinical Trials Conditions at Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV
According to Clinical.Site data, the most researched conditions in "Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV" are
"Breast Cancer" (2 trials), "Breast Carcinoma" (1 trials), "Breast Tumor" (1 trials), "Chemotherapy-induced Nausea and Vomiting" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV
Most popular intervention types in "Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV" are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Carboplatin" (1 trials), "Cyclophosphamide" (1 trials), "Dose-dense Doxorubicin or dose-dense Epirubicin" (1 trials) and "Dronabinol in Oral Dosage Form" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV
The vast majority of trials in "Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV" are
12 trials for "All" genders.
Clinical Trials Status at Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV
Currently, there are NaN active trials in "Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV".
undefined are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV, 2 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".